Mark Munch - 05 Jan 2026 Form 4 Insider Report for BRUKER CORP (BRKR)

Signature
/s/ Michael Simone, Attorney-in-Fact
Issuer symbol
BRKR
Transactions as of
05 Jan 2026
Net transactions value
-$929,671
Form type
4
Filing time
06 Jan 2026, 16:15:20 UTC
Previous filing
19 Aug 2025
Next filing
16 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Munch Mark EXEC VP&PRES BRUKER NANO INC. BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA /s/ Michael Simone, Attorney-in-Fact 06 Jan 2026 0001544635

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BRKR Common Stock Options Exercise $99,988 +4,506 +3.5% $22.19 132,949 05 Jan 2026 Direct
transaction BRKR Common Stock Options Exercise $310,660 +14,000 +11% $22.19 146,949 05 Jan 2026 Direct
transaction BRKR Common Stock Options Exercise $340,328 +15,337 +10% $22.19 162,286 05 Jan 2026 Direct
transaction BRKR Common Stock Sale $225,300 -4,506 -2.8% $50.00 157,780 05 Jan 2026 Direct F1
transaction BRKR Common Stock Sale $700,000 -14,000 -8.9% $50.00 143,780 05 Jan 2026 Direct F1
transaction BRKR Common Stock Sale $755,347 -15,337 -11% $49.25 128,443 05 Jan 2026 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BRKR Stock Option (Right to Purchase) Options Exercise $0 -4,506 -100% $0.000000 0 05 Jan 2026 Common Stock 4,506 $22.19 Direct F3
transaction BRKR Stock Option (Right to Purchase) Options Exercise $0 -14,000 -26% $0.000000 40,337 05 Jan 2026 Common Stock 14,000 $22.19 Direct F4
transaction BRKR Stock Option (Right to Purchase) Options Exercise $0 -15,337 -38% $0.000000 25,000 05 Jan 2026 Common Stock 15,337 $22.19 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.74 to $50.065, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vests in full on the fourth anniversary of the Original Grant Date.
F4 The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.